Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...
Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on...
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...
Singapore - Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...
Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, amon...
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...
Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...
Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...
Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction o...
Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate dru...
PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and ...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sc...
Singapore –Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy ...
First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...
Singapore – A new multicenter, retrospective analysis of South Korean patients highlighted that the oral targeted ...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...
Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mou...
Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, Calif...
Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...
Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 2...
Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...
Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both...
apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...
Singapore - Medivir AB announced plans to reduce activities not critical to its development pipeline of drug candidates ...
Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of ...
Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...
Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...
David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinica...
Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...
Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high ...
A recent article in the Annals of Emergency Medicine reported on the diagnostic accuracy of the newly released Beckman C...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, and Antengene Corporation, a biopharmaceutical company, recen...
Puma Biotechnology, Inc., a biopharmaceutical company, and Strata Oncology, Inc., a precision oncology company, have ent...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...
Northlane Capital Partners has announced that it has made an investment in Firma Clinical Research (“Firma”)...
The Health Sciences Authority has approved Novartis Kisqali (Ribociclib, LEE011), earlier this year as a first-line trea...
Singapore – Scientists from A*STAR’s Institute of Molecular & Cell Biology (IMCB) have discovered a key ...
Singapore – Researchers at A*STAR’s Singapore Bioimaging Consortium (SBIC) have identified a new region of t...
Singapore – Bayer announced results from the Asian analysis of OPTIMIS, the first prospective real-world stud...
Inovio Pharmaceuticals, today announced positive Phase 1 results of its collaborative vaccine study with INO-4700 ...
Singapore- Sorrento Therapeutics announced that it has acquired the Sofusa lymphatic delivery technology platform from K...
Singapore – According to recent research, the insulin resistance and pancreatic beta-cell (β-cell) dysfunctio...
HealthMatch, an Australian start-up aiming to become the go-to platform linking sick patients with clinical trials of po...
Asia-Pacific specialist CRO Novotech has signed a Memorandum of Understanding (MoU) with the China Medical University Ho...
Singapore- Artelo Biosciences, a biopharmaceutical company focused on the development of therapeutic treatments that mod...
Singapore – VistaGen Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commer...
GE Healthcare will provide China-based Xiangxue Pharmaceutical (XPH) with a FlexFactory for cell therapy. The system, ex...
Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
Singapore- TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...
Singapore- Exact Sciences and Mayo Clinic researchers announce progress in developing a panel of blood-based D...
Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...
Singapore- Acasti Pharma, a biopharmaceutical innovator focused on the research, development and commercialization of it...
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorder...
Xynomic Pharma, a clinical stage US-China oncology drug development company, recently announced that it has complete...
Canada's NEOMED-LABS, a global leader in the clinical immunology field, announced a 3-year extension of t...
Singapore- Five Prime Therapeutics, a clinical-stage biotechnology company focused on discovering and developing innovat...
Singapore- Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagn...
Singapore – Repair and regeneration capacity of skeletal tissues diminishes with age, often leading to delaye...
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Singapore- The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products cont...
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in ...
Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...
Singapore – Results published in the International Journal of Cardiology show that the 0-hour/1-hou...
Singapore- In Singapore, about a quarter of people with hypertension are unaware and therefore remain untreated. In addi...
The Turnbull Government is launching a national awareness campaign to get to get more Australians into ground-breaking c...
Singapore- Scientists from A*STAR’s Institute of Molecular & Cell Biology (IMCB) have discovered a mechanism t...
Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...
Singapore– Delcath Systems, an interventional oncology company focused on the treatment of primary and metast...
Singapore- Thermo Fisher Scientific has entered into agreements with Daiichi Sankyo and Takeda Pharmaceutical ...
Thermo Fisher Scientific Inc. announced that manufacturers using additive manufacturing (AM) processes can now easily us...
Singapore, known for some of the world's most stringent drug laws, aims to develop medical treatments containing synthet...
Aspirin can counter the ill effects of obesity on cancer development, according to a study that may pave the way for new...
Singapore – Results from a Phase 3 clinical trial, PROMISE 1, assessing Alder BioPharmaceuticals' long-...
Singapore – Roche unit Genentech announces new four-year data from an open-label extension study o...
Singapore - Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 millio...
Singapore- Fisher & Paykel Healthcare Corporation Limited announced that new research has been published in the ...
Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development o...
Singapore - Abbott announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo st...
